Skip to main content
SpringerLink
Log in

Confronting the Hidden Face of Progesterone During the Follicular Phase

  • Editorial Commentary
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Sporadic cases of late follicular phase progesterone elevation have been described in ART cycles despite routine blockage of endogenous gonadotropins with GnRH agonists, the mechanism of which has been eluding our scrutiny. In this issue of JARG, Levran et al. report the first cases of adult-onset mild form of congenital adrenal hyperplasia (CAH) linked to a deficit in 17-hydorixyloase (17-OH ase). Contrary to CAH due to deficit 21-OH ase, these not only affect the adrenals but also the FSH driven production of E2 and androgen by the ovary thereby leading to progesterone “accumulation” during the follicular phase. Levran's findings offer new hypotheses for explaining the cases late follicular progesterone elevation particularly, when encountered in COH cycles associated with poor E2 elevation. And more importantly, Levran's findings offer new possible options for minimizing their consequences on ART outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCES

  1. Ferenczy A, Bertrand G, Gelfand MM: Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol 1979;133:859–867

    Google Scholar 

  2. Ayoubi JM, Brioschi PA, Fanchin R, Epiney M, Campana A, de Ziegler D. Comparison of changes in uterine contraction frequency after ovulation in the menstrual cycle and in vitro fertilization cycle. Fertil Steril, in press

  3. Levran D, Ben-Shlomo I, Pariente C, Dor J, Mashiach S, Weisman A. Famillial partial 17,20 desmolase and 17-hydroxylase deficiency presenting as infertility. J Assit Reprod Genet, in Press

  4. Schoolcraft W, Sinton E, Schlenker T, Huynh D, Hamilton F, Meldrum DR. Lower pregnancy rate with premature luteinization during pituitary suppression with leuprolide acetate. Fertil Steril 1991;55:563–566

    Google Scholar 

  5. Mio Y, Sekijima A, Iwabe T, Onohara Y, Harada T, Terakawa N. Subtle rise in serum progesterone during the follicular phase as a predictor of the outcome of in vitro fertilization. Fertil Steril 1992;58:159–166

    Google Scholar 

  6. Dirnfeld M, Goldman S, Gonen Y, Koifman M, Lissak A, Abramovici H. A modest increase in serum progesterone levels on the day of human chorionic gonadotropin (hCG) administration may influence pregnancy rate and pregnancy loss in in vitro fertilization-embryo transfer (IVF-ET) patients. J Assist Reprod Genet 1993;10:126–129

    Google Scholar 

  7. Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril 1993;59:1090–1094

    Google Scholar 

  8. Silverberg KM, Burns WN, Olive DL, Riehl RM, Schenken RS. Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J Clin Endocrinol Metab 1991;73:797–803

    Google Scholar 

  9. G Givens CR, Schriock ED, Dandekar PV, Martin MC. Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles. Fertil Steril 1994;62:1011–1017

    Google Scholar 

  10. Hofmann GE, Khoury J, Johnson CA, Thie J, Scott RT Jr. Premature luteinization during controlled ovarian hyperstimulation for in vitro fertilization-embryo transfer has no impact on pregnancy outcome. Fertil Steril 1996;66:980–986

    Google Scholar 

  11. Abuzeid MI, Sasy MA. Elevated progesterone levels in the late follicular phase do not predict success of in vitro fertilization-embryo transfer. Fertil Steril 1996;65:981–985

    Google Scholar 

  12. Lindheim SR, Cohen MA, Chang PL, Sauer MV. Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles. J Assist Reprod Genet 1999;16:242–246

    Google Scholar 

  13. Fanchin R, Righini C, Olivennes F, de Ziegler D, Selva J, Frydman R. Premature progesterone elevation does not alter oocyte quality in in vitro fertilization. Fertil Steril 1996;65:1178–1183

    Google Scholar 

  14. Fanchin R, Righini C, Olivennes F, Ferreira AL, de Ziegler D, Frydman R. Consequences of premature progesterone elevation on the outcome of in vitro fertilization: Insights into a controversy. Fertil Steril 1997;68:799–805

    Google Scholar 

  15. Adonakis G, Deshpande N, Yates RW, Fleming R. Luteinizing hormone increases estradiol secretion but has no effect on progesterone concentrations in the late follicular phase of in vitro fertilization cycles in women treated with gonadotropin-releasing hormone agonist and follicle-stimulating hormone. Fertil Steril 1998;69:450–453

    Google Scholar 

  16. Filicori M, Cognigni GE, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT, Pocognoli P. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J Clin Endocrinol Metab 1999;84:2659–2663

    Google Scholar 

  17. Filicori M, Cognigni GE, Tabarelli C, Pocognoli P, Taraborrelli S, Spettoli D, Ciampaglia W. Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J Clin Endocrinol Metab 2002;87:1156–1161

    Google Scholar 

  18. White PC, Speiser PW: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000;21:245–291

    Google Scholar 

  19. Chetkowski RJ, DeFazio J, Shamonki I, Judd HL, Chang RJ. The incidence of late-onset congenital adrenal hyperplasia due to 21-hydroxylase deficiency among hirsute women. J Clin Endocrinol Metab 1984;58:595–598

    Google Scholar 

  20. Fitness J, Dixit N, Webster D, Torresani T, Pergolizzi R, Speiser PW, Day DJ. Genotyping of CYP21, linked chromosome 6p markers, and a sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999;84:960–966

    Google Scholar 

  21. Knochenhauer ES, Cortet-Rudelli C, Cunningham RD, Conway BA, Dewailly D, Azziz R. Carriers of 21-hydroxylase deficiency are not at increased risk for hyperandrogenism. J Clin Endocrinol Metab 1997;82:479–485

    Google Scholar 

  22. Witchel SF, Lee PA, Suda-Hartman M, Hoffman EP. Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. Biochem Mol Med 1997;62:151–158

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Reproductive Endocrinology and Infertility, Hôpital de Nyon, 1260, Nyon, Switzerland

    Dominique de Ziegler, Pierre-Alain Brioschi & Renato Fanchin

  2. Rimini Hospital, Rimini, Italy

    Carlo Bulletti

Authors
  1. Dominique de Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre-Alain Brioschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Renato Fanchin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlo Bulletti
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Ziegler, D., Brioschi, PA., Fanchin, R. et al. Confronting the Hidden Face of Progesterone During the Follicular Phase. J Assist Reprod Genet 20, 29–32 (2003). https://doi.org/10.1023/A:1021258721796

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021258721796

Search

Navigation